Namphuong Thi Tran MD

PubMed

• 12 citations
  Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): e...
  Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac
  The Lancet. Haematology. 2023-10-01
• Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.
  Eli Silvert, Laura Hester, Eshwan Ramudu, Colin Pawlowski, Britte Kranenburg
  American Journal of Hematology. 2023-09-01
• 11 citations
  Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study.
  Shaji Kumar, Angela Dispenzieri, Divaya Bhutani, Morie Gertz, Ashutosh Wechalekar
  Amyloid. 2023-09-01

Journal Articles

• Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis...  
  NamPhuong Tran, Japanese journal of oncology
• Background: LATITUDE was a randomized, double-blind, international and phase 3 study of abiraterone acetate plus prednisone in patients with high-risk metastatic hormo...  
  NamPhuong Tran, European urology
• Optimal therapeutic strategy remains an unmet need in localised high-risk prostate cancer (LHRPC). Androgen biosynthesis inhibition in the preoperative setting may imp...  
  NamPhuong Tran, European urology
• Background AAP and androgen deprivation therapy (ADT) treatment significantly improved overall survival (OS) and radiological progression-free survival (rPFS) in mCSPC...  
  NamPhuong Tran, Annals of Oncology
• TPS5087 Background: Assessing multiple therapies in a single clinical trial can facilitate the rapid identification of new agents for the treatment of patients with me...  
  NamPhuong Tran, Journal of Clinical Oncology
• Background: In the interim analyses of the LATITUDE study, the addition of abiraterone acetate plus prednisone to androgen deprivation therapy (ADT) led to a significa...  
  NamPhuong Tran, The Lancet oncology
• Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer  
  Karim Fizazi, M.D., Ph.D., NamPhuong Tran, M.D., Luis Fein, M.D., Nobuaki Matsubara, M.D., Alfredo Rodriguez‑Antolin, M.D., Ph.D., Boris Y. Alekseev, M.D., Mustafa Özg..., New England Journal of Medicine, 6/4/2017
• Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancer  
  Kim N Chi, Jennifer Spratlin, Christian Kollmansberger, NamPhuong Tran, The Journal of Clinical Pharmacology, 6/2015
• Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease  
  Y Chen, P G Schlegel, N Tran, N JChao, Blood, 2/1/1997
• Join now to see all